CD274 and neoplasm: The higher survival benefit and better tumor response rates associated with combined radio‐immunotherapy could be attributed to the following mechanisms: The PD‐1 receptor is highly expressed on activated infiltrating T cells induction by the tumor microenvironment, and PD‐L1 is expressed on the surface of tumor cells.